Public Act 0252 104TH GENERAL ASSEMBLY |
Public Act 104-0252 |
| HB2874 Enrolled | LRB104 09796 RLC 19862 b |
|
|
AN ACT concerning criminal law. |
Be it enacted by the People of the State of Illinois, |
represented in the General Assembly: |
Section 5. The Illinois Controlled Substances Act is |
amended by changing Section 216 as follows: |
(720 ILCS 570/216) |
Sec. 216. Ephedrine. |
(a) The following drug products containing ephedrine, its |
salts, optical isomers and salts of optical isomers shall be |
exempt from the application of Sections 312 and 313 of this Act |
if they: (i) may lawfully be sold over-the-counter without a |
prescription under the Federal Food, Drug, and Cosmetic Act; |
(ii) are labeled and marketed in a manner consistent with |
Section 341.76 of Title 21 of the Code of Federal Regulations; |
(iii) are manufactured and distributed for legitimate |
medicinal use in a manner that reduces or eliminates the |
likelihood of abuse; and (iv) are not marketed, advertised, or |
labeled for the indications of stimulation, mental alertness, |
weight loss, muscle enhancement, appetite control, or energy: |
(1) Solid oral dosage forms, including soft gelatin |
caplets, which are formulated pursuant to 21 CFR 341 or |
its successor, and packaged in blister packs of not more |
than 2 tablets per blister. |
|
(2) Anorectal preparations containing not more than 5% |
ephedrine. |
(b) The marketing, advertising, or labeling of any product |
containing ephedrine, a salt of ephedrine, an optical isomer |
of ephedrine, or a salt of an optical isomer of ephedrine, for |
the indications of stimulation, mental alertness, weight loss, |
appetite control, or energy, is prohibited. In determining |
compliance with this requirement the Department may consider |
the following factors: |
(1) The packaging of the drug product; |
(2) The name and labeling of the product; |
(3) The manner of distribution, advertising, and |
promotion of the product; |
(4) Verbal representations made concerning the |
product; |
(5) The duration, scope, and significance of misuse of |
the particular product. |
(c) A violation of this Section is a Class A misdemeanor. A |
second or subsequent violation of this Section is a Class 4 |
felony. |
(d) This Section does not apply to dietary supplements, |
herbs, or other natural products, including concentrates or |
extracts, which: |
(1) are not otherwise prohibited by law; and |
(2) may contain naturally occurring ephedrine, |
ephedrine alkaloids, or pseudoephedrine, or their salts, |
|
isomers, or salts of isomers, or a combination of these |
substances, that: |
(i) are contained in a matrix of organic material; |
and |
(ii) do not exceed 15% of the total weight of the |
natural product. |
(e) Nothing in this Section limits the scope or terms of |
the Methamphetamine Precursor Control Act. |
(f) This Section does not apply to the sale of any product |
dispensed or delivered by a practitioner or pharmacy according |
to a prescription issued by a prescriber authorized by this |
State or another state for a valid medical purpose and in the |
course of professional practice. |
(Source: P.A. 103-881, eff. 1-1-25.) |